Medical Card
Get Your Medical Marijuana Card Today
Meet with a healthcare provider in minutes and receive the best care for the best value.
Explore A-Z conditions
Viral and Prion Disease or Infections of the Central Nervous System (CNS)
Cannabis for Viral and Prion Disease or Infections of the Central Nervous System (CNS)
A prion is a virus-like organism made up of an aggregation of elongated fibrils that make up a prion protein. Aggregations of these proteins make up an infectious prion. Prions are a disease of structurally abnormal proteins, and they attack nerve cells in the brain. Neurodegenerative diseases like Creutzfeldt–Jakob disease (CJD), its variant (vCJD), Gerstmann–Sträussler–Scheinker syndrome (GSS), fatal familial insomnia (FFI), and kuru are prion diseases.
There is little research into the uses of cannabis for prion diseases, but one study suggests that CBD prevents the accumulation of prions and protects neurons against prion toxicity.
Get your medical marijuana card
Connect with a licensed physician online in minutes.
Animal Study
4
Clinical Meta-analysis
1
Laboratory Study
8
Meta-analysis
5
Total studies
Viral and Prion Disease or Infections of the Central Nervous System (CNS)
18
Positive
15 studies
83%
Inconclusive
3 studies
17%
Do I qualify?
Select your state from the drop down and we’ll let you know.
Relevant studies
The information in our comprehensive A to Z encyclopedia comes from real scientific studies.
Uncover the detailed results of these studies and find out how effective medical marijuana is for dozens of conditions.
- Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
- Cannabidiol for Viral Diseases: Hype or Hope?
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- Cannabinoid Inhibition of Macrophage Migration to the Trans-Activating (Tat) Protein of HIV-1 Is Linked to the CB2 Cannabinoid Receptor
- Cannabinoids receptors in Covid-19: Perpetrators and victims